Related Experiment Video
Updated: Nov 20, 2025

08:05
A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence
Published on: March 23, 2022
2.7K
Dopamine and relapse to drug seeking
1School of Psychology, UNSW Sydney, Sydney, NSW, Australia.
Journal of Neurochemistry
|January 24, 2021
Summary
Dopamine is crucial for drug relapse, but its exact role remains unclear. Recent research reveals distinct dopamine pathways and neuron activities drive different forms of relapse, necessitating further investigation.
Area of Science:
- Neuroscience
- Addiction Research
- Neurobiology of Addiction
Background:
- Dopamine plays a critical role in drug seeking and relapse.
- A precise understanding of dopamine's mechanisms in relapse is lacking.
- Recent advancements in understanding dopamine pathways provide new insights.
Purpose of the Study:
- To review recent findings from animal models on how dopamine controls relapse to drug seeking.
- To synthesize current knowledge on the neurochemical, molecular, anatomical, physiological, and functional properties of dopamine pathways involved in relapse.
- To highlight the diversity of dopamine mechanisms underlying different forms of drug relapse.
Main Methods:
- Review of recent literature and animal model studies.
- Analysis of neurochemical, molecular, anatomical, physiological, and functional data.
- Examination of dopamine pathway involvement in various drug seeking relapse behaviors.
Main Results:
- Dopamine is essential for relapse to drug seeking across different drugs of abuse.
- Distinct dopamine mechanisms, including specific circuit-level pathways, dopamine neuron populations, and activity profiles, are involved in different forms of relapse.
- Evidence suggests a complex and varied role for dopamine in driving relapse behaviors.
Conclusions:
- While dopamine is integral to drug relapse, its contribution is not uniform.
- Different types of relapse are mediated by distinct dopamine circuitries and neuronal activities.
- Further research is needed to elucidate the precise temporal, spatial, and mechanistic roles of dopamine in relapse behaviors.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
924
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
924
Drug Dependence
1.4K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.4K
Drugs Affecting Neurotransmitter Synthesis
1.9K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.9K
Desensitization and Tachyphylaxis
2.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.7K
Drugs Affecting Neurotransmitter Release or Uptake
1.4K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.4K
Adrenergic Agonists: Indirect-Acting Agents
2.4K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.4K

